Peter Nagy

Years Active: 2021-2023
Publications (10 Years): 2

This page only lists publications with an associated author ORCID identifier.

Publications

Séverine Vermeire, Silvio Danese, William J Sandborn, Stefan Schreiber, Stephen Hanauer, Geert D'Haens, Peter Nagy, Manoj Thakur, Caleb Bliss, Fabio Cataldi, Martina Goetsch, Kenneth J Gorelick, Walter Reinisch
Efficacy and Safety of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Antibody Ontamalimab in Patients with Moderate-to-Severe Ulcerative Colitis or Crohn's Disease. Journal of Crohn's & colitis (2023)
Geert R D'Haens, Walter Reinisch, Scott D Lee, Dino Tarabar, Edouard Louis, Maria Kłopocka, Jochen Klaus, Stefan Schreiber, Dong Il Park, Xavier Hébuterne, Peter Nagy, Fabio Cataldi, Steven W Martin, Satyaprakash Nayak, Anindita Banerjee, Kenneth J Gorelick, William J Sandborn
Long-Term Safety and Efficacy of the Anti-Mucosal Addressin Cell Adhesion Molecule-1 Monoclonal Antibody Ontamalimab (SHP647) for the Treatment of Crohn's Disease: The OPERA II Study. Inflammatory bowel diseases (2021)

Peter Nagy.css-eqlu8i{font-size:small;padding-left:4px;}